Dr. Laura E. Raffals, MD

Dr. Raffals practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Raffals' NPI, 1538222054, was assigned on December 18, 2006. Dr. Raffals graduated from Indiana University School Of Medicine in 1998. Dr. Raffals' Minnesota license number on file is 54748.

Dr. Raffals' primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Raffals' primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Raffals to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raffals practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Raffals' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Raffals is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Raffals' licenses on file in 2 states: Minnesota and Illinois.

Dmand AI lists chronic inflammatory bowel disease (IBD), colonoscopy and upper GI endoscopy among the conditions Dr. Raffals treats.

CMS data shows 82 Medicare services from Dr. Raffals across 4 procedure codes in 2024, for 101 Medicare patients. Medicare paid $7,739 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 101 Medicare patients who saw Dr. Raffals in 2024. The largest group is 65 to 74, with 56 patients. 64% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Raffals' median patient age at 65, with 62% women.

In 2024, Dr. Raffals wrote 142 Medicare Part D claims for 49 patients. CMS names the drug for 70 of them, across 4 drugs with 11 or more claims each, at $990,204 in total drug cost. In 2023, CMS named 117 claims across 6 drugs.

Dr. Raffals accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Raffals as offering telehealth. CMS counts 22 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Raffals, more than 51% of the clinicians it reports for that procedure.

Dmand AI links 98 papers to Dr. Raffals, published from 2013 to 2025. 2022 was the busiest year, with 8. The most frequent topics are Inflammatory Bowel Diseases, Colitis, Ulcerative and Crohn Disease. Dr. Raffals has published most often in Inflamm Bowel Dis. Dr. Raffals' most frequent co-authors are Edward Vincent Loftus, MD, William A. Faubion, MD and Amy Lee Lightner, MD.

Dmand AI links Dr. Raffals to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Colitis, Ulcerative, Colitis and Crohn Disease. Mayo Clinic sponsors the most, 2.

CMS Open Payments shows 24 general payments to Dr. Raffals from 5 drug and device companies from 2017 to 2023. Consulting fees make up the largest share, 86% of the total. Ferring Pharmaceuticals Inc. paid the most, $9,269.

Dmand AI lists 11 awards for Dr. Raffals, most recently GIH Teaching Award in 2014.

Dr. Raffals graduated from Indiana University School Of Medicine in 1998.

Dr. Raffals is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.